Skip to main content
Small molecule therapeutics for Kabuki syndrome and related disorders

Small molecule therapeutics for Kabuki syndrome and related disorders

Unmet Need Kabuki syndrome is a developmental disorder characterized by a distinctive set of facial features, short stature, intellectual disability, dermatoglyphic abnormalities, and internal malformations of cardiac, renal, gastrointestinal, and/or skeletal systems. The global prevalence…

Read More

Non-opioid treatment for chronic pain using a neurotensin receptor 1 modulator

Non-opioid treatment for chronic pain using a neurotensin receptor 1 modulator

Unmet Need For individuals experiencing chronic pain, day-to-day tasks and activities can become difficult or impossible. It can also lead to other long-term health challenges including insomnia, stress, anxiety, and depression. Chronic pain is so…

Read More

Use of rifaximin and bacterial strains for treating probable neurodegenerative disorders like Alzheimer’s Disease

Use of rifaximin and bacterial strains for treating probable neurodegenerative disorders like Alzheimer’s Disease

Unmet Need There is an urgent need to develop novel therapies for neurodegenerative diseases and conditions such as Alzheimer's disease (AD). Ten percent of people over age 65 and up to 50% over age 85…

Read More

Topical PHD inhibitors to enhance wound healing by reducing ischemia

Topical PHD inhibitors to enhance wound healing by reducing ischemia

Unmet Need Millions of patients experience unhealed skin wounds, and with the rise in number of surgeries per year along with the increase in older population, this burden is expected to increase. One aspect of…

Read More

Endocrine cancer treatment method using glycerate

Endocrine cancer treatment method using glycerate

Unmet Need Endocrine cancers, those that affect organs that secrete hormones, are among the most common cancers in the U.S. Tumors that form in the organs of the endocrine system often secrete excess hormones or…

Read More

Topical MEK inhibition as a new modality for inflammatory skin diseases and cancers

Topical MEK inhibition as a new modality for inflammatory skin diseases and cancers

Unmet Need Inflammatory skin conditions affect many people, with a wide range of severities. Common skin disorders, such as psoriasis and atopic dermatitis, affect close to 20% of the population. Skin lesions associated with bone…

Read More

Method to sensitize cancer radiotherapy and chemotherapy

Method to sensitize cancer radiotherapy and chemotherapy

Unmet Need While radiotherapy and/or chemotherapy are used for >90% of cancer patients in clinical settings, the therapeutic outcomes are far from ideal for many types of tumors due to the development of drug resistance…

Read More

Melanoma treatment method using estrogen modulating small molecules

Melanoma treatment method using estrogen modulating small molecules

Unmet Need Metastatic melanoma, skin cancer that has spread, is an incredibly deadly cancer, with a median survivorship of 6-9 months. For patients with melanoma, a frequently used therapy is immune checkpoint blockade (ICB). These…

Read More

A process to selectively access allylic diamines that can aid in identifying new drug compounds

A process to selectively access allylic diamines that can aid in identifying new drug compounds

Unmet Need When developing new drugs, researchers often rely on naturally occurring compounds to learn what design features illicit a biological response that can be tailored for treating a given disease or ailment. However, reproducing…

Read More

A method of treating and preventing gastrointestinal disorders

A method of treating and preventing gastrointestinal disorders

Unmet Need Gastrointestinal disorders such as inflammatory bowel disease, constipation, and intestinal pseudo-obstruction have been estimated to affect more than 40% of adults worldwide. These disorders are often associated with alterations in gut microbiota, which…

Read More

Clenbuterol Therapy for Amyotrophic Lateral Sclerosis

Clenbuterol Therapy for Amyotrophic Lateral Sclerosis

Unmet Need Amyotrophic lateral sclerosis (ALS) is a debilitating disease with progressive loss of muscle function and inevitable death usually in 3-5 years. There are currently two available therapies on the market which prolong life…

Read More

A stable, easily manufactured intranasal oxytocin formulation that contains only food grade preservatives

A stable, easily manufactured intranasal oxytocin formulation that contains only food grade preservatives

Unmet Need Current formulations of oxytocin used for the treatment of neuropsychiatric disorders have several drawbacks. For example, many intravenous and intranasal formulations, like those approved in Europe, contain preservatives like chlorobutanol which is highly…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us